Paul Spano Email & Phone Number

I was promoted into this sales leadership position and am currently developing and implementing strategies to increase sales of Lucemyra (first & only FDA-approved, non-opioid, treatment for relief of multiple symptoms of opioid withdrawal) by leading, coaching, mentoring, and training 7 reps covering the Western half of the US. • Work individually with sales reps in each territory to analyze opportunities, develop strategies to overcome challenges, assist with accessing top prescribing accounts, increasing sales, and building confidence of each rep. • Contribute to the success of the region by building a strong culture, ensuring attainment of goals, collaborating with corporate headquarters on strategy execution, preparing sales forecasts, and managing regional budget.

I was hired into a brand-new territory (East TN, WV, Western NC, Upstate SC) to launch and drive prescription growth for Lucemyra by calling on pain and addiction specialists. • 2023: Continued to drive growth and surpass expectations for the year, achieving 100%+ of sales quota in Q1, Q2, and Q3, and began transition into the Regional Director role in Q4. • 2022: Won President’s Club and the Out of the Park Award for sales performance; ranked #5 in the US for new prescriber growth and produced 110% of quota in Q1, 114% in Q2, 134% in Q3, and 116% in Q4.

I was hired as part of a new sales force to launch Repatha (injectable biologic for treating high cholesterol sold through specialty pharmacies) with cardiologists and key high volume primary care physicians in a large territory covering East Knoxville to Wytheville, VA. Extensively involved with advising accounts on reimbursement issues and patient pull-through for a complex sales process. • 2015 - 2018: 2018 #19/243 nationally, Received Amgen’s Two-Year Team Excellence Award for 2015 and 2016; 2017 ranked #1/5 in the region and #52/243 nationally for sales performance; generated 81% market share versus the company average of 55%; and maintained 80% market share with top 20 cardiologists in the territory. • Fulfilled several sales training and district/regional leadership roles including: - Acting District Manager during absence of the current District Manager for two different districts. - Lead district sales training/compliance meetings as a District Trainer and Compliance Coordinator. - Selected to participate on the newly formed Southeast Advisory Council.

After Merck’s acquisition of Schering Plough in 2010, I launched Liptruzet and increased growth of Zetia and Vytorin (cholesterol lowering agents) with Cardiologists, Endocrinologists, Oncologists and Internal Medicine. While with Schering Plough from 2000 to 2010, I sold Zetia and Vytorin to primary care and specialty physicians and also sold the respiratory portfolio (Claritin, Proventil, Vanceril, Nasonex) to Asthma, Allergy and Pulmunology Specialists. Achievements included: • Fulfilled several sales training and district/regional leadership roles including: - Interim District Manager for Louisville, managing 12 reps, preparing coaching reports, approving expense reports, and creating district sales plans. - District Trainer for seven years, performing field ride alongs to train reps on selling techniques. - Two months at home office as a Corporate Trainer, training new reps on medications and selling strategies. - One of only three Southeast Regional Trainers for two years. - Completed Leadership Development Training in 2008 for promotion to District Manager. - Appointed by Regional Director to Southeast Region Leadership Council. • 2014: Ranked #4 in the region despite market share losses due to Liptruzet being pulled off market in January 2014. • 2013: Ranked #3 overall in Semester 2 and #14 in the US out of 500 reps for Liptruzet; • 2012 & 2011: This was part of the Schering Plough to Merck (No sales results provided). • 2010 & 2009: Top 20% in the US for 2010 and Top 18% for 2009. • 2008 & 2007: Top 30% for 2008, winning 2008 MVP Award; finished top 5% in US. • 2006 & 2005: #1 in district for Zetia launch and Top 5% in region in 2006; ranked Top 10% in region in 2005. • 2004 & 2003: Top 10% market share in the US for 2004 and District Rep of the Year in 2003.

I established a successful record of (B2B) business-to-business sales results in an extremely competitive industry selling high-end architectural, commercial, industrial roofing and flooring systems to major hospital in public school system accounts throughout East Tennessee. Sales accomplishments and recognition included: • Increased sales volume from zero to $440,000 annually in less than five years. • Won "Rookie of the Year" out of 31 candidates selling industrial roofing and flooring throughout East Tennessee. • Three-time winner of the annual Raynow Award in 1996, 1997 and 1999 for achieving 150% of quota.